Latest article

GeoVax Reports 2025 Year-End Financial Results and Provides Business Update

2026 Biotech 12 Pack Editor / Curator -
LIVE QUOTE Pivotal Phase 3 Trial for GEO-MVA (Mpox/Smallpox Vaccine) Scheduled to Initiate During the Second Half of This Year ATLANTA, GA - April 15, 2026 (NEWMEDIAWIRE)...

Danger Will Robinson: the NIPAH virus with a 40-75% Death Rate.

2026 Vaccine Stock Watch List Editor / Curator -
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity Click to...

Report: AI Powered Review on GeoVax (GOVX) $1.15

2026 Biotech 12 Pack Editor / Curator -
In our view, a research report is designed to gather information on publicly traded companies from press releases, management presentations (including power points), SEC...